Direkt zum Inhalt
Merck
  • Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and alpha-benzylaminobenzylphosphonic acid update the mechanistic picture and offer new insights into inhibitor design.

Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and alpha-benzylaminobenzylphosphonic acid update the mechanistic picture and offer new insights into inhibitor design.

Biochemistry (2003-01-15)
Eric Ortlund, Michael W LaCount, Lukasz Lebioda
ZUSAMMENFASSUNG

The X-ray crystal structure of human prostatic acid phosphatase (PAP) in complex with a phosphate ion has been determined at 2.4 A resolution. This structure offers a snapshot of the final intermediate in the catalytic mechanism and does not support the role of Asp 258 as a proton donor in catalysis. A total of eight hydrogen bonds serve to strongly bind the phosphate ion within the active site. Bound PEG molecules from the crystallization matrix have allowed the identification of a channel within the molecule that likely plays a role in molecular recognition and in macromolecular substrate selectivity. Additionally, the structure of PAP in complex with a phosphate derivative, alpha-benzylaminobenzylphosphonic acid, a potent inhibitor (IC(50) = 4 nM), has been determined to 2.9 A resolution. This structure gives new insight into the determinants of binding hydrophobic ligands within the active site and allows us to explain PAP's preference for aromatic substrates.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Phosphatase, sauer aus Weizenkeimen, ≥0.4 unit/mg solid
Sigma-Aldrich
Phosphatase, sauer aus Kartoffeln, lyophilized powder, ≥0.5 unit/mg solid
Sigma-Aldrich
Phosphatase, sauer aus Kartoffeln, lyophilized powder, ≥3.0 units/mg solid
Sigma-Aldrich
Phosphatase, sauer aus Süsskartoffeln, ammonium sulfate suspension, ≥10.0 units/mg protein (modified Warburg-Christian)
Sigma-Aldrich
5′-Nucleotidase human, recombinant, expressed in CHO cells, vial of 6-12 μg